Open Access Open Access  Restricted Access Access granted  Restricted Access Subscription or Fee Access

Vol 105, No 4 (2024)

Cover Page

Full Issue

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Theoretical and clinical medicine

Characteristics of immunocompetent cells in the testicles of different age group patients with COVID-19

Demyashkin G.A., Boldyrev D.V., Vadyukhin M.A., Alieva L.N., Shirinov E.N.

Abstract

BACKGROUND: There is an opinion that the new coronavirus infection COVID-19 can initiate the development of a local inflammatory reaction in the testicles, which leads to damage to spermatogenic epithelial cells and a decrease in the fertility of patients in the long term.

AIM: Morphofunctional assessment of immunocompetent cells in the testicles of patients with COVID-19 depending on age.

MATERIAL AND METHODS: Based on anamnestic, clinical and morphological data, groups of patients were formed, each of which included subgroups according to the age periodization of the World Health Organization: the first group of patients who died as a result of COVID-19 (n=109; average age 58±2.8 years) — young subgroup (n=19, age 18–44 years), middle-aged subgroup (n=37, age 45–59 years), elderly subgroup (n=53, age 60–74 years); second group (n=30, average age 49±2.3 years; autopsy material from the testicles of patients who died from causes unrelated to COVID-19, obtained outside the pandemic) — a subgroup of young people (n=10, age 18–44 years), middle-aged subgroup (n=10, age 45–59 years), elderly subgroup (n=10, age 60–74 years). Histological and immunohistochemical studies were carried out using primary antibodies to CD3, CD4, CD68, CD163, CD138 and statistical methods: Kolmogorov–Smirnov test, Student's t-test, Mann–Whitney U test and Fisher test.

RESULTS: All testicular samples from patients with COVID-19 revealed signs of viral orchitis and a significant decrease in the spermatogenesis index (in young people — 5.9±0.2% with p=0.02; in middle age — 5.1±0.2% with p=0.008; in the elderly — 3.6±0.1% at p=0.006) compared to the control group (6.8±0.3%), and in immunohistochemical studies — an increase in the number of T-lymphocytes (CD3+, CD4+), macrophages (CD68+, CD163+) and plasma cells (CD138+) in interstitial tissue. In addition, a significant decrease in the spermatogenesis index (3.6±0.1% in the elderly versus 5.9±0.2% in the young, p=0.007) and a decrease in the number of T-lymphocytes (CD3+, CD4+) and macrophages (CD68+, CD163+) was found in older versus younger patients with COVID-19.

CONCLUSION: In patients with COVID-19, an increase in the number of immunocompetent cells (CD3+, CD4+, CD68+, CD138+, CD163+) in the interstitial tissue of the testicles was found, especially pronounced in the elderly group.

Kazan medical journal. 2024;105(4):533-542
pages 533-542 views

Evaluation of the treatment effectiveness in patients with stage IIB–IIIB ovarian cancer

Zhurman V.N.

Abstract

BACKGROUND: The relevance of the study is due to the urgent problem of assessing therapy effectiveness for stage IIB–IIIB ovarian cancer.

AIM: Study of patients' survival rates after surgical treatment of various forms of stages IIB–IIIB of ovarian cancer depending on a number of clinical and morphological factors.

MATERIAL AND METHODS: The material for the study was long-term observations of patients who received treatment from 2004 to 2021 at the Primorsky Regional Oncology Dispensary, the source was the medical record of an inpatient (form 003/u). The group of patients with stage IIB–IIIB ovarian cancer consisted of 107 patients, average age 50.7±11.5 years. Of these, 43 (40.2%) were women with stage IIB, 46 (43.0%) patients with stage IIIA, 3 (2.8%) patients with stage IIIA2, 15 (14.0%) patients with stage IIIB. Overall survival and progression-free survival were assessed. Statistical methods included survival analysis using the Kaplan–Meier method with the construction of survival curves, medians and standard errors of survival time, and comparison of survival between groups of patients using the log-rank test.

RESULTS: In patients with low-grade serous carcinoma, the five-year progression-free survival rate was higher than in patients with high-grade serous carcinoma (71.1±13.5 and 39.5±7.7%, respectively; p <0.01). Primary surgical treatment performed in gynecological hospitals reduced the median life expectancy and five-year survival rate by 150.0 months and 25.9% (p <0.01; RR=3.4; 95% CI=1.2–9.4). Interval cytoreduction reduced the median time to progression and five-year progression-free survival in patients with stage IIB–IIIB ovarian cancer (53.0±35.2 months and 43.7±16.5%) compared with patients underwent primary surgery (70.0±37.5 months and 57.3±6.0%). The five-year survival rate was higher in patients receiving a combination of platinum and taxanes — 94.7±5.1% (p <0.01; HR=0.2; 95% CI=0.05–0.5).

CONCLUSION: In patients with stage IIB–IIIB ovarian cancer, factors such as primary surgical treatment performed in specialized gynecological oncology hospitals and adjuvant chemotherapy with platinum drugs in combination with taxane agents statistically significantly increase survival.

Kazan medical journal. 2024;105(4):543-550
pages 543-550 views

Association of galectins-1 and -3 with proangiogenic factors and endothelial dysfunction in colon cancer

Kurnosenko A.V., Reyngardt G.V., Poletika V., Kolobovnikova Y.V., Urazova O.I.

Abstract

BACKGROUND: A key role in the pathogenesis of colon cancer is assigned to inducers of neoangiogenesis — vascular endothelial and epidermal growth factors, the effects of which can probably be modulated by galectins-1 and -3.

AIM: To study the relationship between the content of galectins-1 and -3, vascular endothelial and epidermal growth factors with the number of circulating endothelial cells in the blood of patients with colon cancer, depending on the degree of tumor differentiation and its spread.

MATERIAL AND METHODS: Patients (n=20) with a verified diagnosis of colon cancer (International Classification of Diseases code C18–C20) were examined; the comparison group included healthy volunteers (n=10), matched by gender and age. The study material was peripheral blood. The content of galectin-1, galectin-3, vascular endothelial and epidermal growth factors was assessed by enzyme immunoassay, and counting of desquamated endothelial cells was assessed by flow cytometry. Statistical processing was performed in the Jamovi 2.3.21 software package for Windows. Differences between samples were assessed by calculating the Mann–Whitney U test. Relationships were established by calculating the Spearman correlation coefficient (ρ). The results were considered reliable at the level of statistical significance p <0.05.

RESULTS: In patients with colorectal cancer, the level of vascular endothelial factor was higher than in healthy donors by 18%, the level of galectin-1 was 2.6 times higher, galectin-3 was 1.6 times higher compared to healthy donors, the level of epidermal growth factor did not differ significantly. The content of galectins-1 and -3 was closely interrelated (ρ=0.843, p <0.01), with the content of vascular endothelial growth factor in the blood plasma (ρ=0.311, p=0.032 — galectin-1; ρ=0.310, p <0.033 — galectin-3, respectively). The number of desquamated endothelial cells in the blood of patients with colorectal cancer was 8 times higher than in healthy people, and directly correlated with the content of vascular endothelial growth factor (ρ=0.307, p <0.05), galectin-1 (ρ=0.650, p <0.01) and galectin-3 (ρ=0.622, p <0.01).

CONCLUSION: An increase in the content of galectins-1 and -3 in the blood plasma of patients with colon cancer positively correlates with the expression of vascular endothelial growth factor, and does not depend on the stage of the disease and the degree of tumor differentiation.

Kazan medical journal. 2024;105(4):551-559
pages 551-559 views

Results of surgical treatment of adrenocortical cancer

Kotelnikova L.P., Fedachuk A.

Abstract

BACKGROUND: Adrenalectomy is the only possible method of radical treatment of adrenocortical cancer, and surgical approach (laparotomy or laparoscopy) remains a subject of debate.

AIM: To evaluate one-year mortality in patients with adrenocortical cancer and determine its relationship with age, stage of the disease, tumor characteristics according to computed tomography results, and surgical approach.

MATERIAL AND METHODS: In the Perm Regional Clinical Hospital, over the past 7 years, 107 patients have been operated on for adrenal tumors, of which 15 (14.01%) people were diagnosed with adrenocortical cancer. Adrenalectomy was performed by open (11) and laparoscopic (4) approaches. The results were assessed by the number of local relapses of the disease and life expectancy. Statistical analysis was carried out using standard application programs Statistica for Windows 10.0. Nonparametric methods of descriptive statistics were used. To determine the relationship between individual pairs of characteristics and the degree of its severity, the Spearman correlation coefficient (r) was calculated.

RESULTS: Stage I of the disease according to the ENSAT classification was found in 1 case, II — in 7, III — in 5, IV — in 2 cases. The size of tumors removed laparoscopically was significantly smaller (p=0.042) compared to those operated on with an open approach. One-year survival rate was 80%. Surgical approach and combined operations did not affect one-year mortality (r=0.277; p=0.298 and r=–0.462; p=0.071). A relationship was found between lethal outcomes and age (r=–0.539; p=0.030), and the rate of washout of the contrast agent from the tumor in the delayed phase when performing computed tomography (r=–0.845; p=0.034). In case of lethal outcomes, the rate of washout of the contrast agent was the lowest. The life expectancy of patients depended on the stage of the disease (r=–0.590; p=0.016).

CONCLUSION: One-year mortality in patients with adrenocortical cancer was 20% and had a moderate positive correlation with age, stage of the disease and a strong correlation with tumor characteristics based on bolus-enhanced computed tomography, but had no relationship with the chosen surgical approach.

Kazan medical journal. 2024;105(4):560-566
pages 560-566 views

Comorbidity of chronic heart failure of ischemic etiology and chronic obstructive pulmonary disease: 5-year follow-up

Khazova E.V., Boulashova O.V., Iakubova V.M., Malkova M.I.

Abstract

BACKGROUND: The combination of chronic heart failure and chronic obstructive pulmonary disease contributes to the formation of the phenotype and survival of patients.

AIM: To study the 5-year prognosis and develop a prognostic model of adverse events in patients with chronic heart failure of ischemic origin in comorbidity with chronic obstructive pulmonary disease.

MATERIAL AND METHODS: Clinical signs of patients with chronic heart failure of ischemic origin (n=517), including those in combination with chronic obstructive pulmonary disease (n=118), and outcomes over 5 years according to end points: death from all causes, cardiovascular death, composite endpoint — all fatal and non-fatal cardiovascular events, were studied. Quantitative variables were presented as mean and standard deviation or median and interquartile range; categorical — in the form of absolute value and percentage. Quantitative intergroup differences were assessed using the Mann–Whitney test, and categorical differences were assessed using the Pearson χ2 test. Time to event was analyzed using the Kaplan–Meier method; hazard ratio — by Cox regression. Models were developed using binary logistic regression. Statistical processing was carried out in the Jamovi, R 4.3.1 programs.

RESULTS: The clinical portrait of a patient with chronic heart failure of ischemic origin in the presence of chronic obstructive pulmonary disease was characterized by a predominance of men in older age groups, a high frequency of smoking, a worse quality of life, determined by the Minnesota Questionnaire, and a high level of high-sensitivity C-reactive protein, α1- and α2-globulins. Patients with heart failure in the presence of chronic obstructive pulmonary disease had higher overall and cardiovascular mortality (p=0.029 and p=0.02), the frequency of hospitalizations not related to cardiovascular disease (p=0.02), less non-fatal cardiovascular events (p=0.04).

CONCLUSION: In patients with heart failure, the presence of chronic obstructive pulmonary disease increased the risk of death from all causes by 2.07 times, cardiovascular mortality by 2.24 times, and achieving the combined endpoint by 1.68 times. Regression models were developed to determine the probability of risk of death from all causes and cardiovascular death.

Kazan medical journal. 2024;105(4):567-577
pages 567-577 views

Experimental medicine

System proteinase/inhibitors in the pathogenesis of experimental kidney tuberculosis

Esmedlyaeva D.S., Alekseeva N.P., Blum N.M., .Dyakova M.E., Vinogradova T.I.

Abstract

BACKGROUND: Damage to the kidney parenchyma of various origins is associated with the accumulation of extracellular matrix proteins, the regulation of which involves the matrix metalloproteinase/inhibitor system.

AIM: To evaluate the pathogenetic role of the proteinase/blood inhibitor system in experimental renal tuberculosis.

MATERIAL AND METHODS: When modeling the process, a clinical strain 5582 of the Beijing genotype with multidrug resistance of mycobacteria was used. The study was conducted on 20 rabbits, divided into three groups: the first (n=6) included infected untreated animals; in the second (n=7) and third (n=7) anti-tuberculosis therapy was administered orally for 18.5 weeks; in the third, treatment was carried out in combination with a single injection of autologous mesenchymal stem cells into the ear vein. Blood levels of matrix metalloproteinases-1 and -9, tissue inhibitor of metalloproteinases-1, cystatin C and neutrophil elastase were determined. Morphological changes in the kidney parenchyma at the end of the experiment were assessed using 26 indicators, including tubulointerstitial and vascular changes. The median and interquartile ranges were calculated, the Kruskal–Wallis test, analysis of covariance, and the projective classification method were used.

RESULTS: The progression of kidney tuberculosis was accompanied by a significant increase in the level of neutrophil elastase by 1.9 times, matrix metalloproteinase-9 by 2.2 times, and cystatin C by 1.5 times compared to the initial level. The treatment carried out in the second and third groups contributed to the normalization of these indicators. The concentrations of matrix metalloproteinase-1 and tissue inhibitor of metalloproteinase-1 in all three groups did not change relative to the baseline level. Covariance analysis showed that in the pathogenesis of renal tuberculosis changes in matrix metalloproteinase-1 (p=0.003), matrix metalloproteinase-9 (p=0.002), tissue inhibitor of metalloproteinases-1 (p=0.01) and cystatin C (p=0.0001) were primarily associated with vascular changes, found in all study groups. A linear combination containing three morphological characteristics allowed us to identify differences between the three groups with 90% accuracy.

CONCLUSION: Renal tuberculosis, caused by a multidrug-resistant pathogen, is characterized by an imbalance in the proteinase/inhibitor system and impaired renal function, the degree of which is associated with the morphological characteristics of vascular and tubulointerstitial changes.

Kazan medical journal. 2024;105(4):578-587
pages 578-587 views

Comparative assessment of the osmotic and anti-inflammatory activity of soft dosage forms of pyrimidine drugs on hydrophilic bases in an experiment

Izmailov A.G., Dobrokvashin S.V., Izmailov S.G., Lukoyanychev E.E., Zharinov A.Y.

Abstract

BACKGROUND: Despite the constant search for new medications for local prevention of surgical infection, the problem of purulent-inflammatory complications from postoperative soft tissue wounds remains relevant to this day.

AIM: To experimentally study the osmotic activity and anti-inflammatory properties of the developed xymedone-containing ointment composition levoxycol in comparison with the well-known ointment dioxomethyltetrahydropyrimidine + chloramphenicol (levomekol).

MATERIAL AND METHODS: The anti-inflammatory properties of the ointments were studied in vivo on 60 outbred male Wistar rats, which were divided into three groups, 20 animals each. The first group served as control. In the second group of animals, levomekol ointment was used, in the third group — levoxycol. An assessment of the osmotic activity of the experimental ointment composition levoxycol in comparison with a known drug was carried out in an in vitro experiment. To evaluate the anti-inflammatory activity of ointments, a model of carrageenan-induced edema of rat paws was used. To analyze differences in the frequency of the studied outcomes in groups of animals, the Mann–Whitney U test was used.

RESULTS: Osmotic activity showed that wipes soaked in ointment forms absorbed the following amount of contrast (Me [Q1; Q3]): levomekol — 28.2 (26.4; 31.3) ml; levoxycol — 41.8 (39.5; 43.4) ml (p=0.001). The anti-inflammatory activity of the ointment forms manifested itself in the form of suppression of swelling of the rats' paws at 3 and 5 hours after the injection of carrageenan. When using the ointment form of levomekol, the volume of displaced liquid with the introduction of carrageenan, starting from 3 hours, was 1.8±0.19 ml. When using the ointment form of levoxicol, the amount of displaced liquid when carrageenan was administered, starting from 3 hours, was 1.57±0.16 ml (p=0.013).

CONCLUSION: In vitro experiments have shown that the ointment form of levoxicol has a longer osmotic activity; experimental data in vivo indicated that the use of the developed ointment form of levoxicol, in contrast to the ointment form of levomekol, has a positive effect on the course of inflammatory processes in soft tissues in the first 2–3 hours by reducing the volume of displaced fluid.

Kazan medical journal. 2024;105(4):588-595
pages 588-595 views

Reviews

The role of the placenta in the formation of gestational complications in women with metabolic syndrome

Orazmuradov A.A., Mukovnikova E.V., Bekbaeva I.V., Orazmuradova A.A., Suleymanova Z.Z.

Abstract

Over the past decade, the prevalence of metabolic syndrome has increased significantly worldwide, and in most countries around the world this non-communicable disease has become a major health threat. Today, the mechanisms of metabolic syndrome influence on the development of various pregnancy complications are actively discussed. Studies of the pathophysiological mechanisms of the relationship between metabolic disorders and placental-associated pregnancy complications deserve special attention. The placenta performs essential functions throughout pregnancy and serves as a site for nutrient exchange and gas exchange between the pregnant woman and the fetus. Metabolic changes in women are closely associated with a number of placentally mediated obstetric complications, including preeclampsia, placental insufficiency, macrosomia, fetal growth restriction and antenatal fetal death. It is believed that it is in the first trimester of pregnancy that trophoblast cells are most sensitive to metabolic changes in homeostasis, which leads to their ischemia, impaired proliferation, invasion and angiogenesis. In pregnancies complicated by metabolic syndrome, the placenta is exposed to inflammation, oxidative stress, dyslipidemia, hyperglycemia, and altered hormone levels. Such metabolic changes can affect the development and function of the placenta, leading to abnormal fetal growth, as well as metabolic and cardiovascular disorders in children in the long term. Despite the wide range of pregnancy complications with metabolic syndrome, the mechanisms of their development have not been sufficiently studied. The purpose of this review was to summarize current knowledge about the pathophysiological mechanisms of the influence of metabolic syndrome on the development and function of the placenta.

Kazan medical journal. 2024;105(4):596-606
pages 596-606 views

Treatment of arterial hypertension in patients with chronic kidney disease from the perspective of the 2023 European recommendations

Sigitova O.N.

Abstract

Hypertension is a common disease in the adult population with an increasing tendency, it leads to damage to target organs, including the kidneys, with the development of chronic kidney disease, and increases the risk of cardiovascular complications and mortality. The paper provides an overview of the European guidelines for the treatment of arterial hypertension, updated in 2023, approved by the European Kidney Association and the International Society of Hypertension, in the context of chronic kidney disease — in comparison with the previous European guidelines (2018) and the current National clinical guidelines (2021). The updated recommendations retain the main provisions of the strategy for the treatment of arterial hypertension with chronic kidney disease of the 2018 European recommendations. Updates have been made to the classification of the main and additional groups of drugs for the treatment of arterial hypertension. For the first time, a new group of “special drugs for the treatment of concomitant pathology” has been added, including three classes of drugs: (1) neprilysin receptor antagonists, (2) sodium-glucose transporter-2 inhibitors, (3) non-steroidal mineralocorticoid receptor antagonists. A step-by-step algorithm for choosing antihypertensive drugs for arterial hypertension depending on the stage of chronic kidney disease has been updated. Recommendations for the treatment of resistant arterial hypertension were covered in detail. Some new recommendations were included for blood pressure targets based on albuminuria levels and other factors. A slightly modified scale for assessing cardiovascular risk in patients with arterial hypertension was presented and the role of chronic kidney disease stages III–V as an independent factor of high or very high cardiovascular risk was confirmed.

Kazan medical journal. 2024;105(4):607-621
pages 607-621 views

Alzheimer’s disease: risk factors, cellular and molecular basis of pathogenesis, analysis of pathogenetic mechanisms in comparison with amyotrophic lateral sclerosis

Akhmadieva L.A., Nagiev K.K., Zefirov A.L., Mukhamedyarov M.A.

Abstract

Alzheimer’s disease is a neurodegenerative disease characterized by progressive neurocognitive dysfunction. Today, studying the pathogenesis of this disease remains an urgent problem. The review describes the pathogenetic basis of Alzheimer’s disease, including not only extracellular deposition of amyloid plaques and intracellular hyperphosphorylation of tau protein with subsequent formation of neurofibrillary tangles, but also mitochondrial dysfunction, impaired autophagy, neuroinflammation, etc. Data are presented on the effect of hyperphosphorylated tau protein on the breakdown and enhancement of β-amyloid peptide synthesis. Oligomerized tau protein causes proteasomal dysfunction and oxidative stress. Mitochondrial dysfunction is closely related to oxidative stress, which can be both a cause and a consequence. Autophagy, namely mitophagy, in turn, also plays an important role in the development of mitochondrial dysfunction. It can be argued that neuroinflammation is associated with all of the listed links in pathogenesis. This review also examines the influence of intestinal dysbiosis on the development of the disease. The complex mutual influence of pathogenetic mechanisms forms a multicomponent network of pathological processes. Understanding the Alzheimer’s disease pathogenesis is necessary in the search for methods for correcting impaired functioning mechanisms of the nervous system, which will help develop effective methods for treating this disease. In addition, to better understand the mechanisms of Alzheimer’s disease development, it is necessary to search for common pathogenetic factors with other neurodegenerative diseases.

Kazan medical journal. 2024;105(4):622-636
pages 622-636 views

A systematic review of the safety and efficacy of platelet-rich plasma for the treatment of posttraumatic knee osteoarthritis

Leonova E.I., Chirinskaite A.V., Sopova J.V.

Abstract

Injury of the knee joint can lead to a range of adverse outcomes and significantly contributes to the development of the knee osteoarthritis. Currently, autologous platelet-rich plasma is used as a promising and safe method of treating osteoarthritis. Such plasma contains various growth factors, some of which are secreted after platelet activation. These factors can trigger a regenerative response and improve the metabolic functions of damaged structures. However, there are different protocols for preparing platelet-rich plasma, which results in preparations with different amounts of bioactive substances. As a result, the data obtained on the effect of platelet-rich plasma on the restoration of hyaline cartilage of the knee joint are very contradictory. A search for publications on a given topic was performed in the eLIBRARY, PubMed (MEDLINE), Ovid, Science Direct, Google Scholar databases, and also a search was conducted for clinical trial data on the treatment of knee osteoarthritis with platelet-rich plasma over the past 20 years. Publications dealing with other aspects of the application of this technology were excluded from the search results. An analysis of published clinical trial results found that, in most cases, patients treated with platelet-rich plasma reported improved pain and joint function, with only three studies showing no difference between platelet-rich plasma and placebo. Thus, this technology is generally promising for use in the treatment of knee osteoarthritis, however, methods of obtaining and activating platelet-rich plasma, as well as the age and comorbidities of the patient, may affect the effectiveness of therapy.

Kazan medical journal. 2024;105(4):637-647
pages 637-647 views

Cellular mechanisms of age-dependent bone remodeling

Plekhova N.G., Krivolutskaya P.A., Chernenko I.N.

Abstract

The structural integrity of the skeleton is ensured by the constant remodeling of bone tissue, which is based on the functioning and interaction of osteolytic cells (osteoclasts) and bone tissue forming cells (osteoblasts/osteocytes). Despite the general understanding that the degree of mineralization of the bone matrix determines the fragility of the skeleton, there is currently insufficient information about its age-related changes associated with the functioning of these cells. The purpose of the review is to evaluate existing data on age-related bone changes associated with the functional state of mesenchymal stem cells, osteoblasts/osteocytes and osteoclasts. Inclusion criteria: randomized or non-randomized controlled studies examining age-related bone change. A search for studies in the field of bone tissue condition was carried out in electronic scientific databases Google Scholar, Medline, PubMed, Scopus, Web of Science and Cochrane Library by keywords and their combinations using the AMSTAR 2 program. The selection of publications (59 out of 680 included) was carried out randomly, after which three authors independently assessed their methodological quality. The main pathogenetic mechanism involved in bone loss with age is a decrease in the formation of osteoblasts with impairment of their ability to osteogenic differentiation. Osteocytes in old age are subject to excessive and prolonged stress, which causes unbalanced autophagy and apoptosis, which leads to changes in their ability to deposit and mineralize extracellular organic matrix. With age, accelerated osteoclastogenesis occurs, mediated by osteoblasts, which leads to increased expression of certain receptors at the level of bone stromal cells and osteoblasts. The presented literature data demonstrate convincing evidence that an increase in bone resorption due to complex metabolic processes with age occurs against the background of an increase in the number and activity of osteoclasts, apoptosis of osteoblasts with a decrease in their metabolic activity, as well as a redistribution of osteogenic differentiation of mesenchymal stem cells towards adipocytes. The results presented in the review can be used as a basis for developing diagnostic criteria for identifying senile osteoporosis and the risk of fractures.

Kazan medical journal. 2024;105(4):648-660
pages 648-660 views

Clinical observations

Giant subcapsular hematoma of the liver — a rare complication after laparoscopic cholecystectomy

Slavin L.E., Galimzyanov A.F., Zimagulov R.T., Yakhin R.R., Sangadzhiev S.B.

Abstract

The article shows a clinical case of an extremely rare complication after laparoscopic cholecystectomy — a giant subcapsular hematoma of the liver. The clinical, laboratory and instrumental data of the patient and the results obtained were analyzed. Analysis of the data from the operated patient did not reveal the main reason that could have caused the development of a giant subcapsular hematoma of the liver. The patient had no bleeding disorders, had not previously suffered any bleeding, and did not take anticoagulants as an outpatient. During the operations, no source of bleeding or damage to the liver parenchyma was identified. In addition, there was no evidence of focal liver lesions according to the preoperative ultrasound scan. Outpatient use of a drug from the group of antiplatelet agents, as well as short-term irregular use of analgesics to relieve periodic pain could provoke the development of this complication. Treatment of subcapsular hematoma of the liver mainly depends on the clinical condition of the patient and the size of the hematoma. With conservative management, the condition of the formed hematoma should be more carefully monitored over time using radiation diagnostic methods. If necessary and according to indications, do not exclude possible repeated laparoscopic intervention, including conversion to laparotomy, taking into account the data of clinical, laboratory and radiological research methods. In most cases, this condition requires conservative treatment. Patients with such a complication require careful hemodynamic monitoring and visual monitoring of the complications development. Probably, preference should be given to magnetic resonance imaging, since this method is the most objective and does not carry a radiation load. The main task is not to miss the moment of hematoma rupture and the development of fatal bleeding.

Kazan medical journal. 2024;105(4):661-668
pages 661-668 views

Clinical case of multivisceral en bloc resection for locally advanced cancer of the colon hepatic flexure

Egorov V.I., Akhmetzyanov F.S., Kaulgud H.A., Ruvinskiy D.M.

Abstract

BACKGROUND: Currently, 15–20% of colorectal cancer cases are diagnosed at the locally advanced T4b stage. Treatment of this category of patients causes significant difficulties due to the degree of prevalence and the presence of a complicated course of the disease itself.

AIM: Demonstration of a clinical case with an operation — multivisceral resection with pancreatoduodenal resection — for locally advanced cancer of the right half of the colon, as well as the oncological rationale for this operation.

MATERIAL AND METHODS: This paper describes a case of treatment of a female patient with locally advanced adenocarcinoma of the colon hepatic angle, complicated by toxic-anemic syndrome and symptoms of partial intestinal obstruction. She underwent en bloc multivisceral resection with pancreatoduodenal resection.

RESULTS: The patient was discharged on the 10th day after surgery in satisfactory condition, no complications were registered. Subsequently, adjuvant treatment was carried out: 5 courses of therapeutic polychemotherapy according to the XELOX regimen (capecitabine was received on an outpatient basis at a dose of 1500 mg 2 times a day, course 2 weeks). 12 months after surgery, progression of the disease in the form of metastases to the lungs was established, and 6 courses of bevacizumab therapy were administered. Currently the process has stabilized.

CONCLUSION: A clinical case demonstrates the possibility of R0 resection for locally advanced cancer of the colon hepatic flexure with ingrowth into the liver, pancreas, duodenum and achieving good long-term results.

Kazan medical journal. 2024;105(4):669-676
pages 669-676 views

History of medicine

Personal development and professional path of the outstanding domestic odontologist, Professor G.I. Vilga

Pashkov K.A., Bondar' V.A.

Abstract

The article presents for the first time a complete scientific biography of Gilarii-Zdislav Ivanovich Vilga, created on the basis of archival and literary sources of the early twentieth century. G.I. Vilga was a recognized founder of Russian forensic dentistry and one of the founders of Russian maxillofacial surgery. However, his services to domestic dentistry were not limited to this. Signs of the institutionalization of dentistry in Russia at the end of the 19th and beginning of the 20th centuries were the reform of education (private dental schools, the first departments of odontology at universities), the emergence of specialized societies, congresses and the press. Professor G.I. Vilga was one of the first private assistant professors of odontology at Moscow University, the founder of the Moscow dental school and its head, chairman of the Moscow Odontological Society and editor of its printed organ, board chairman of the Russian Dental Union and two All-Russian Dental Congresses. All this gives us the right to consider him one of the founders of domestic dentistry.

Kazan medical journal. 2024;105(4):677-685
pages 677-685 views

100 years of Infectious Diseases Department of Kazan State Medical University

Nikolaeva I.V., Murtazina G.K.

Abstract

In June 2024, the Department of Infectious Diseases of Kazan State Medical University celebrated its 100th anniversary. The department was organized during a tense epidemic situation on infectious diseases in Russia due to the need for specialized training of medical personnel, as well as conducting active scientific research on infectious pathology. Throughout the history of the department, its staff included outstanding scientists and talented teachers who were not only engaged in scientific research and the educational process, but also actively participated in the fight against infectious diseases in practical healthcare. Currently, the staff of the department is actively introducing advanced teaching methods, conducting scientific research, developing protocols and clinical recommendations. Numerous graduates of the department, who have received the specialty of infectious disease doctor, work effectively in all corners of our country.

Kazan medical journal. 2024;105(4):686-694
pages 686-694 views

Cochrane Review Summaries

Undernutrition as a risk factor for tuberculosis disease

Abstract

This publication is the Russian translation of the Plain Language Summary (PLS) of the Cochrane Systematic Review: Franco JVA, Bongaerts B, Metzendorf MI, Risso A, Guo Y, Peña Silva L, Boeckmann M, Schlesinger S, Damen JAAG, Richter B, Baddeley A, Bastard M, Carlqvist A, Garcia-Casal MN, Hemmingsen B, Mavhunga F, Manne-Goehler J, Viney K, Bellorini J. Undernutrition as a risk factor for tuberculosis disease. Cochrane Database of Systematic Reviews. 2024. Issue 6. Art. No. CD015890. doi: 10.1002/14651858.CD015890.pub2

Kazan medical journal. 2024;105(4):695-696
pages 695-696 views


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies